Ioannis Kottakis

518 total citations
21 papers, 414 citations indexed

About

Ioannis Kottakis is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Ioannis Kottakis has authored 21 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 11 papers in Pulmonary and Respiratory Medicine and 4 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Ioannis Kottakis's work include Asthma and respiratory diseases (11 papers), Inhalation and Respiratory Drug Delivery (7 papers) and Air Quality and Health Impacts (4 papers). Ioannis Kottakis is often cited by papers focused on Asthma and respiratory diseases (11 papers), Inhalation and Respiratory Drug Delivery (7 papers) and Air Quality and Health Impacts (4 papers). Ioannis Kottakis collaborates with scholars based in Greece, Switzerland and United States. Ioannis Kottakis's co-authors include Daniela Acerbi, G. Brambilla, Diamantis Chloros, Lazaros Sichletidis, C. Cattaneo, Xavier Jaumont, Thomas Müller, Erminio Bonizzoni, Charlotte Keywood and Óscar Palomares and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, European Respiratory Journal and The Journal of Allergy and Clinical Immunology In Practice.

In The Last Decade

Ioannis Kottakis

19 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ioannis Kottakis Greece 12 207 191 77 56 35 21 414
Mario Polverino Italy 13 176 0.9× 261 1.4× 19 0.2× 16 0.3× 48 1.4× 39 499
J. Wesley Sublett United States 14 109 0.5× 61 0.3× 136 1.8× 51 0.9× 54 1.5× 25 372
Erik R. Swenson United States 3 254 1.2× 554 2.9× 13 0.2× 50 0.9× 35 1.0× 4 708
Roberta Ginanni Italy 14 288 1.4× 347 1.8× 93 1.2× 19 0.3× 167 4.8× 20 708
Emin Özkaya Türkiye 13 150 0.7× 92 0.5× 91 1.2× 5 0.1× 12 0.3× 33 344
Mariana Couto Portugal 12 244 1.2× 199 1.0× 64 0.8× 4 0.1× 29 0.8× 39 414
Marie Chatham United States 9 198 1.0× 177 0.9× 53 0.7× 11 0.2× 199 5.7× 10 495
Gregory J. Argyros United States 12 386 1.9× 416 2.2× 21 0.3× 12 0.2× 17 0.5× 16 630
Vı́ctor Bustamante Spain 12 123 0.6× 211 1.1× 10 0.1× 7 0.1× 51 1.5× 28 428
Jessica Brussee Netherlands 8 254 1.2× 161 0.8× 99 1.3× 4 0.1× 47 1.3× 8 390

Countries citing papers authored by Ioannis Kottakis

Since Specialization
Citations

This map shows the geographic impact of Ioannis Kottakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioannis Kottakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioannis Kottakis more than expected).

Fields of papers citing papers by Ioannis Kottakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioannis Kottakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioannis Kottakis. The network helps show where Ioannis Kottakis may publish in the future.

Co-authorship network of co-authors of Ioannis Kottakis

This figure shows the co-authorship network connecting the top 25 collaborators of Ioannis Kottakis. A scholar is included among the top collaborators of Ioannis Kottakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioannis Kottakis. Ioannis Kottakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Papi, Alberto, et al.. (2022). Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A Combination Therapy for Asthma. Current Respiratory Medicine Reviews. 18(2). 77–85. 1 indexed citations
2.
Molimard, Mathiéu, et al.. (2021). Performance Characteristics of Breezhaler® and Aerolizer® in the Real-World Setting. Clinical Drug Investigation. 41(5). 415–424. 12 indexed citations
4.
Li, Jing, Jing Yang, Lingfei Kong, et al.. (2020). Efficacy and safety of omalizumab in patients with moderate-to-severe asthma: An analytic comparison of data from randomized controlled trials between Chinese and Caucasians. Asian Pacific Journal of Allergy and Immunology. 40(3). 223–231. 8 indexed citations
5.
Humbert, Marc, Jean Bousquet, Claus Bachert, et al.. (2019). IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy. The Journal of Allergy and Clinical Immunology In Practice. 7(5). 1418–1429. 76 indexed citations
6.
Κostikas, Κonstantinos, Robert Fogel, Andreas Clemens, et al.. (2019). Clinical consequences of late Chronic Obstructive Pulmonary Disease (COPD) diagnosis compared to early diagnosis in UK primary care. PA2497–PA2497. 2 indexed citations
7.
Κatsaounou, Paraskevi, Mikaëla Odemyr, Anne Lindberg, et al.. (2018). Smoking and severe persistent asthma. PA1230–PA1230. 1 indexed citations
8.
Κatsaounou, Paraskevi, Mikaëla Odemyr, Michael E. Hyland, et al.. (2018). Asthma patients are Still Fighting for Breath. PA5493–PA5493.
9.
Cattaneo, C., et al.. (2017). Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson’s Disease. Journal of Parkinson s Disease. 7(4). 629–634. 55 indexed citations
10.
Li, Jing, Jian Kang, Changzheng Wang, et al.. (2016). Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study. Allergy Asthma and Immunology Research. 8(4). 319–319. 43 indexed citations
11.
Yang, Jing, Michael Humphries, Shuang Ren, et al.. (2015). Evaluation of omalizumab therapy in a Chinese versus predominantly Caucasian population: Comparison of clinical data. PA4038–PA4038. 1 indexed citations
12.
Sichletidis, Lazaros, et al.. (2006). High prevalence of smoking in Northern Greece. Primary Care Respiratory Journal. 15(2). 92–97. 23 indexed citations
13.
Acerbi, Daniela, G. Brambilla, & Ioannis Kottakis. (2006). Advances in asthma and COPD management: Delivering CFC-free inhaled therapy using Modulite® technology. Pulmonary Pharmacology & Therapeutics. 20(3). 290–303. 55 indexed citations
14.
Sichletidis, Lazaros, et al.. (2005). Prevalence of Chronic Obstructive Pulmonary Disease and Rhinitis in Northern Greece. Respiration. 72(3). 270–277. 38 indexed citations
15.
Sichletidis, Lazaros, et al.. (2005). The effects of environmental pollution on the respiratory system of children in western Macedonia, Greece.. PubMed. 15(2). 117–23. 24 indexed citations
16.
Chloros, Diamantis, et al.. (2005). The effect of environmental pollution on the respiratory system of lignite miners: a diachronic study.. PubMed. 95(6). 452–64. 13 indexed citations
17.
Chloros, Diamantis, et al.. (2004). Respiratory effects in workers processing dried tobacco leaves. Allergologia et Immunopathologia. 32(6). 344–351. 10 indexed citations
18.
Kottakis, Ioannis, Manolis Tzatzarakis, Aristidis Tsatsakis, et al.. (2004). Penetration of newer quinolones in the empyema fluid. European Respiratory Journal. 24(3). 466–470. 20 indexed citations
19.
Panagou, Panagiotis, Ioannis Kottakis, Αrgyris Τzouvelekis, Stavros Anevlavis, & Demosthenes Bouros. (2004). Use of interrupter technique in assessment of bronchial responsiveness in normal subjects. BMC Pulmonary Medicine. 4(1). 11–11. 13 indexed citations
20.
Bouros, Demosthenes, et al.. (1992). Massive Bilateral Pleural Effusion as the Only First Presentation of Systemic Lupus Erythematosus. Respiration. 59(3). 173–175. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026